Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 911-916 , November 2010

Comparison of l-type amino acid transporter 1 expression and l-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer

  • Kyoichi Kaira

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 27 220 8136; fax: +81 27 220 8136.
    • ,
  • Noboru Oriuchi

      Affiliations

    • Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Kimihiro Shimizu

      Affiliations

    • Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Hisao Imai

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Hideyuki Tominaga

      Affiliations

    • Department of Molecular Imaging, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Noriko Yanagitani

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Noriaki Sunaga

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Takeshi Hisada

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Tamotsu Ishizuka

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Yoshikatsu Kanai

      Affiliations

    • Division of Bio-system Pharmacology, Graduate School of Medicine, Osaka University, Osaka, Japan
    • ,
  • Tetsunari Oyama

      Affiliations

    • Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Masatomo Mori

      Affiliations

    • Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
    • ,
  • Keigo Endo

      Affiliations

    • Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan

Received 27 March 2010 ,Revised 6 May 2010 ,Accepted 1 June 2010.

References 

  1. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev. 1990;70:43–77
  2. McGivan JD, Pastor-Anglada M. Regulatory and molecular aspects of mammalian amino acid transport. Biochem J. 1994;299:321–334
  3. Oxender DL, Christensen HN. Evidence for two types of mediation of neutral amino acid transport in Ehrlich cells. Nature. 1963;197:765–767
  4. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273:23629–23632
  5. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human l-type amino acid transporter 1 (LAT 1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291–302
  6. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of l-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer. Br J Cancer. 2008;98:742–748
  7. Takeuchi K, Ogata S, Nakanishi K, Ozeki Y, Hiroi S, Tominaga S, et al. LAT1 expression in non-small-cell lung carcinomas: analysis by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases). Lung Cancer. 2010;68:58–65
  8. Tomiyoshi K, Amed K, Muhammad S, Higuchi T, Inoue T, Endo K, et al. Synthesis of new fluorine-18 labeled amino acid radiopharmaceutical: l-F-alpha-methyl tyrosine using separation and purification system. Nucl Med Commun. 1997;18:169–175
  9. Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, et al. 18F α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med. 1999;40:399–405
  10. Watanabe H, Inoue T, Shinozaki T, Yanagawa T, Ahmed AR, Tomiyoshi K, et al. PET imaging of musculoskeletal tumors with fluorine-18 α-methyl tyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Eur J Nucl Med. 2000;27:1509–1517
  11. Inoue T, Koyama K, Oriuchi N, Alyafei S, Yuan Z, Suzuki H, et al. Detection of malignant tumors: whole-body PET with fluorine-18-α-methyl tyrosine versus FDG-preliminary study. Radiology. 2001;220:54–62
  12. Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, et al. Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest. 2007;131:1019–1027
  13. Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, et al. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res. 2007;13:6369–6378
  14. Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, et al. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer. J Nucl Med. 2009;50:1770–1776
  15. Mountain CF. Revision in the International System for Staging Lung Cancer. Chest. 1997;11:1710–1717
  16. Oriuchi N, Tomiyoshi K, Inoue T, Ahmed K, Sarwar M, Tokunaga M, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med. 1996;37:457–462
  17. Zhang H, Inoue T, Alyafei S, Tian M, Oriuchi N, Ichikawa A, et al. Fundamental study of hot spot detectability in 3-dimensional positron emission tomography. Ann Nucl Med. 2000;14:279–284
  18. Inoue T, Oriuchi N, Kunio M, Tomiyoshi K, Tomaru Y, Aoyagi K, et al. Accuracy of standardized uptake value (SUV) measured by simultaneous emission and transmission scanning in PET oncology. Nucl Med Commun. 1999;20:849–857
  19. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer. 2009;66:120–126
  20. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci. 2009;100:249–254
  21. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. CD98 expression is associated with poor prognosis in resected non-small cell lung cancer with lymph node metastasis. Ann Surg Oncol. 2009;16:3473–3481
  22. Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, et al. l-Type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology. 2009;54:804–813
  23. Ohkame H, Masuda H, Ishii Y, Kanai Y. Expression of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models. J Surg Oncol. 2001;78:265–271[discussion 271--2]
  24. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. l-Type amino acid transporter 1 (LAT1) and CD98 expression in the primary site and the metastatic site of human neoplasms. Cancer Sci. 2008;99:3280–3286
  25. Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, et al. Evaluation of thoracic tumors with 18F-FMT and 18F-FDG PET-CT: a clinicopathological study. Int J Cancer. 2008;124:1152–1160
  26. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. Expression of l-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathol Res Pract. 2008;204:553–561
  27. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. l-Type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas. J Surg Oncol. 2009;99:433–438
  28. Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, et al. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci. 2009;100:753–758
  29. Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y, et al. Present role and future prospect of positron emission tomography in clinical oncology. Cancer Sci. 2006;97:1291–1297

☆ Conflicts of interest statement: We have no financial or personal relationships with other people or organizations that could inappropriately influence our work.

PII: S0969-8051(10)00310-0

doi: 10.1016/j.nucmedbio.2010.06.004

Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 911-916 , November 2010

Article Tools

* Image Usage & Resolution